Anti-Inflammatory Thalidomide Improves Islet Grafts Survival and Functions in a Xenogenic Environment
Chunguang Chen, Carina Kuehn, Reinhard G. Bretzel et al. · 2009
Read Anti-Inflammatory Thalidomide Improves Islet Grafts Survival and Functions in a Xenogenic Environment by Chunguang Chen, Carina Kuehn, Reinhard G. Bretzel et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006312.txt.
Description
Transplanting insulin-making islet cells across species usually fails as inflammation destroys the graft. Chunguang Chen and colleagues tested thalidomide in such a xenogenic transplant model in a 2009 PLOS ONE paper. The drug is known for both anti-inflammatory and anti-vessel-growth properties.
Thalidomide improved the survival and function of the islet grafts in mice, per the title. Calming inflammation around foreign tissue can outweigh the drug's other effects. Islet transplantation is a hoped-for cure for some diabetes patients. Repurposed drugs that protect grafts could widen its use.
Catalog record
| CREATOR | Chunguang Chen, Carina Kuehn, Reinhard G. Bretzel et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006312